3MINDIANSE3M India Limited· TradingMediumNeutral
Announced Wed, 27 May · 09:23 IST

3M India Limited has informed the Exchange about Investor Presentation

Analyst Day Multiyear TargetsOrder Pipeline DisclosedInvestor Communications View source PDF

3MINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹33165.00
prior close
₹33445.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.1+0.3-0.3-1.3-2.3-1.4-1.9-3.0-4.7+0.5+1.0+6.1
Up moveDown movePending
AI summary

3M India held an investor meeting presenting FY 2025-26 results showing sales of INR 5,090 crores, up 14.5% YoY. PAT was INR 522 crores (10.2% of sales), though excluding exceptional items (APA/VSV), adjusted PAT was INR 662 crores (12.9% of sales) with a 0.2 percentage point improvement. All four business segments showed strong growth: Healthcare led at 17.5%, followed by Consumer at 15.6%, Safety & Industrial at 16.0%, and Transportation & Electronics at 10.1%. The company operates 3 manufacturing plants, 1 R&D center, and 2 customer technical centers with ~1,273 employees. Management outlined growth strategies focusing on commercial excellence, local R&D, local supply chain, and talent development. The board saw leadership changes with Radhika Rajan completing her term as Chairperson and Ramesh Ramadurai retiring as Managing Director, while Kavita Nair joined as Independent Director.

Likely market impact

Strong topline growth of 14.5% demonstrates solid demand across all segments, though the reported PAT margin contracted slightly due to exceptional items. The analyst meeting with multiyear strategy details provides visibility into the company's growth roadmap, which could be positive for institutional investors.